Axsome Therapeutics (AXSM) Free Cash Flow (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Axsome Therapeutics | 11.82 Bn | 11.51 Bn | 176.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.20% |
| Dec 31, 2025 | -1,995.14% |
| Sep 30, 2025 | 103.05% |
| Jun 30, 2025 | 25.80% |
| Mar 31, 2025 | -66.64% |
| Dec 31, 2024 | -40.12% |
| Sep 30, 2024 | 37.93% |
| Jun 30, 2024 | 43.69% |
| Mar 31, 2024 | -76.38% |
| Dec 31, 2023 | 43.68% |
| Sep 30, 2023 | 2.82% |
| Jun 30, 2023 | -841.65% |
| Mar 31, 2023 | 78.76% |
| Dec 31, 2022 | -21.56% |
| Sep 30, 2022 | 32.43% |
| Jun 30, 2022 | -2.77% |
| Mar 31, 2022 | -13.96% |
| Dec 31, 2021 | -6.68% |
| Sep 30, 2021 | -6.38% |
| Jun 30, 2021 | 6.73% |
| Mar 31, 2021 | -32.43% |
| Dec 31, 2020 | -30.63% |
| Sep 30, 2020 | 16.66% |
| Jun 30, 2020 | 18.84% |
| Mar 31, 2020 | -32.52% |
| Dec 31, 2019 | -65.27% |
| Sep 30, 2019 | -22.44% |
| Jun 30, 2019 | 8.61% |
| Mar 31, 2019 | 3.01% |
| Dec 31, 2018 | -65.42% |
| Sep 30, 2018 | 22.88% |
| Jun 30, 2018 | -14.67% |
| Mar 31, 2018 | -6.42% |
| Dec 31, 2017 | 2.48% |
| Sep 30, 2017 | 9.14% |
| Jun 30, 2017 | -6.94% |
| Mar 31, 2017 | 8.08% |
| Dec 31, 2016 | -48.05% |
| Sep 30, 2016 | 8.40% |
| Jun 30, 2016 | -34.56% |
| Mar 31, 2016 | -75.54% |
| Dec 31, 2015 | -17.03% |
| Sep 30, 2015 | 8.60% |
| Jun 30, 2015 | -80.33% |